TOP FLAT MAGNETIC STIMULATION FOR PELVIC PAIN IN MEN

Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) has a significant negative impact on people’s quality of life. Aims: the objective of this study was to evaluate the efficacy and the safety of a new device that uses Top Flat Magnetic stimulation to treat hypertonia in men affected by CP/CPPS condition.

20 male patients affected by CPPS underwent 8 treatment sessions which were conducted twice weekly for four consecutive weeks. Data were collected at baseline and 1-month follow-up (1MFU) after the last treatment session. The Italian version of The National Institute of Health Chronic Prostatitis Symptom Index (NIHCPSI) was administered to all patients. The mean “pain” score, “urinary symptoms” and patient’s quality of life (“QL”) were evaluated at baseline and 1MFU after the last treatment session. The mean pain score was also assessed using the Pain Intensity Visual Analog Scale (VAS). In addition, The International Index of Erectile Function (IIEF) was provided before and 1MFU after the last treatment session. All possible side effects were evaluated.

Changes in the total mean NIHCPSI score significantly decreased from 31.5 (±2.9) at baseline to 12.75 (±3.5) at 1MFU after the last treatment session showing an improvement in CP/CPPS symptoms. The total mean IIEF score significantly increased from 21.3 (±2.7) at baseline to 24.3 (±0.5) at 1MFU after the last treatment session, showing better erectile functioning. Finally, also the mean VAS score significantly decreased from 7 (±1.0) at baseline to 3 (±0.9) at 1MFU after the last treatment session.

Based on the study results, this technology could represent a new treatment option for CP/CPPS conditions.

none.